Literature DB >> 16689656

Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation.

Sherry H-Y Wei1, Andrew Ming-Lum, Ying Liu, David Wallach, Christopher J Ong, Stephen W Chung, Kevin W Moore, Alice L-F Mui.   

Abstract

The cytokine interleukin-10 (IL-10) is an important regulator of immune cell function, proliferation, and survival. The IL-10 receptor (IL-10R) consists of two subunits, IL-10R1 and IL-10R2, both belonging to the class II cytokine receptor superfamily. Like other members of the cytokine receptor superfamily, IL-10R stimulation leads to activation of Jak family kinases and Stat transcription factors. To identify additional signal transduction pathways used by the IL-10R, we purified 92-kDa and 100-kDa proteins that coprecipitated with IL-10R1 from IL-10-stimulated cells. Both proteins were found to be related to the 97-kDa subunit of the regulatory component of the 26S proteasome. Subsequent studies confirmed that the IL-10R1 undergoes ligand- dependent internalization and proteasome-mediated degradation. An IL-10R1 cytoplasmic domain mutant deficient for internalization exhibited prolonged signaling through Jak1 and Stat3, reinforcing the importance of receptor internalization for signal termination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689656     DOI: 10.1089/jir.2006.26.281

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  10 in total

Review 1.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

2.  An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Authors:  M Finsterbusch; V Khare; C Campregher; R Evstatiev; C Gasche
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

3.  TGFβ produced by IL-10 redirected astrocytes attenuates microglial activation.

Authors:  Diana M Norden; Ashley M Fenn; Allison Dugan; Jonathan P Godbout
Journal:  Glia       Date:  2014-02-25       Impact factor: 7.452

4.  Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties.

Authors:  Sung Il Yoon; Brandi C Jones; Naomi J Logsdon; Bethany D Harris; Srilalitha Kuruganti; Mark R Walter
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

5.  SNPs in the bovine IL-10 receptor are associated with somatic cell score in Canadian dairy bulls.

Authors:  Chris P Verschoor; Sameer D Pant; Flavio S Schenkel; Bhawani S Sharma; Niel A Karrow
Journal:  Mamm Genome       Date:  2009-07-30       Impact factor: 2.957

Review 6.  The molecular basis of IL-10 function: from receptor structure to the onset of signaling.

Authors:  Mark R Walter
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

7.  Lack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic simian immunodeficiency virus infection.

Authors:  Diganta Pan; Carys S Kenway-Lynch; Wendy Lala; Ronald S Veazey; Andrew A Lackner; Arpita Das; Bapi Pahar
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

8.  Regulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligase.

Authors:  Hui Jiang; Yi Lu; Liang Yuan; Jianghuai Liu
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

9.  Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.

Authors:  Sabine G Gruber; Maria Gloria Luciani; Paul Grundtner; Alexander Zdanov; Christoph Gasche
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 6.688

10.  Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection.

Authors:  Nicholas A Cilfone; Cory R Perry; Denise E Kirschner; Jennifer J Linderman
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.